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Summary 
Background 
This report by the Australian Institute of Health and Welfare (AIHW) and the National 
Breast Cancer Centre (NBCC) provides descriptive statistics of relative survival to 2006 in 
Australian women diagnosed with invasive breast cancer in 1997. In addition, the data 
quantify the associations of size and nodal status with survival in Australia, both in general 
and by age at diagnosis, place of residence and socioeconomic status. 
This report is a follow-up of Breast cancer size and nodal status (AIHW & NBCC 2001). Data 
consisted of 10,017 cases of women diagnosed with breast cancer in 1997; of these cases, there 
were 3,323 deaths up to 31 December 2006. 
Key findings 
• Survival was considerably higher for women with smaller tumours compared with 
women diagnosed with larger tumours. Specifically, 5-year relative survival was 98% for 
women with cancers 10 mm in size or less and declined to 73% for women with cancers 
30 mm or more and to 49% for women with unknown tumour size. 
• Similarly, survival was significantly higher in women whose lymph nodes were  
cancer-free (negative nodal status) compared with women whose cancer had spread to 
their lymph nodes (positive nodal status). Specifically, 5-year relative survival was 97% 
when nodes were negative, 80% when nodes were positive and 71% when nodal status 
was unknown. 
• Women with unknown tumour size and nodal status had the lowest relative survival 
throughout the analyses. Survival in these women may be poor because of advanced  
co-morbidity, frailty for reasons of age or other factors where a comprehensive 
investigation and treatment of their cancers was not deemed to be warranted. 
• Age effects were analysed, with poorer survival in women aged less than 40 years and 
aged 70 years and over.  
• Survival was also highest among women living in major city areas and in areas with 
highest socioeconomic status. 
• Some groups of women showed a relative survival greater than 100%. Although these 
figures are based on small numbers, they may validly occur in women with successful 
early diagnosis and treatment to reduce the risk of dying below the risk of women in the 
general community. 
 1 
1 Introduction 
Data sources 
The primary data source was a special collection of all female invasive breast cancer cases in 
1997 which was provided by state and territory cancer registries for the report Breast cancer 
size and nodal status (AIHW & NBCC 2001). A summary of these records is presented in Table 
1.1. These records were then linked with the AIHW National Death Index for death records 
from 1 January 1997 to 31 December 2006. 
 
Table 1.1: Breast cancer cases diagnosed in 1997: size of cancer by state and territory 
  Size 
 0–10 mm 11–15 mm  16–19 mm 20–29 mm 30+ mm Unknown  Total 
State/ 
territory No. %  No. %   No. %  No. %  No. %  No. %   No. 
% of 
total
NSW 718 20.6 739 21.2  383 11.0 754 21.7 559 16.1 327 9.4  3,480 34.7
Vic 465 18.2 543 21.2  261 10.2 560 21.9 387 15.1 345 13.5  2,561 25.6
Qld 413 23.6 385 22.0  184 10.5 335 19.1 299 17.1 135 7.7  1,751 17.5
WA 193 21.1 201 22.0  97 10.6 177 19.4 132 14.4 114 12.5  914 9.1
SA 121 13.6 174 19.5  91 10.2 183 20.5 204 22.8 120 13.4  893 8.9
Tas 38 16.5 57 24.8  26 11.3 43 18.7 48 20.9 18 7.8  230 2.3
ACT 23 16.6 37 26.6  14 10.1 32 23.0 24 17.3 9 6.5  139 1.4
NT 7 14.3 12 24.5  6 12.2 8 16.3 9 18.4 7 14.3  49 0.5
Australia 1,978 19.8  2,148 21.4   1,062 10.6  2,092 20.9  1,662 16.6  1,075 10.7   10,017 100.0
Source: National Cancer Statistics Clearing House, AIHW. 
Relative survival 
Relative survival analysis compares the survival rate of persons diagnosed with cancer 
(observed survival) with the survival rate of the entire Australian population of the same sex 
and age in the same calendar year as the cancer cohort (expected survival). The relative 
survival is defined as the observed survival divided by the expected survival and is usually 
given as a percentage. For example, a 5-year relative survival of 89% for women diagnosed 
with breast cancer in 1997 and who were aged 60–64 years at diagnosis means that a person 
from that category has an 89% chance of surviving 5 or more years relative to all Australian 
females aged 60–64 years in 1997. 
The software used to compute the relative survival figures was written by Dickman (2004).  
It uses the Ederer II method of computing the interval-specific expected survivals. All of the 
cancers in this study were diagnosed in a single year and therefore the period and cohort 
methods of analysis yield identical results. 
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Caveats 
• Tumour size is the largest diameter of the excised tumour. However, in the case of 
multifocal tumours (where a number of tumours have arisen at the same time), there was 
a difference in measurement methodology between jurisdictions. In South Australia and 
the Northern Territory tumour size was recorded as the sum of the diameters of all the 
tumours whereas in the other jurisdictions tumour size was recorded as the diameter of 
the largest tumour. Therefore the tumour sizes in records from South Australia and 
Northern Territory are a little inflated compared with the rest of Australia. However, this 
would have little if any bearing on the results herein because the number of records of 
multifocal tumours in those two jurisdictions are very small compared with the total 
number of records used in this study. 
• During data preparation it was discovered that a tumour size record of 0 mm was 
ambiguous. Some coders in some jurisdictions meant a tumour of microscopic size 
whereas others meant that the size was unknown. A separate survival analysis was 
performed on this set of records. The results indicated very poor survival for such 
women. As this scenario does not accord with the rest of the study, where there is a clear 
trend of decreasing survival for increasing tumour size, it was felt that most of the 0 mm 
records must in fact be of unknown tumour size. As there was no way to separate the 
two kinds of 0 mm records it was decided to reclassify all of them as being of unknown 
tumour size. 
• Information about socioeconomic status and remoteness was determined using 
postcodes of women at the time of diagnosis, i.e. in 1997. It should be noted that women 
may move to different geographic areas after diagnosis. Although not analysed here, a 
patient’s place of residence and socioeconomic status following diagnosis may also affect 
breast cancer survival. 
• Various tables in the next chapter show some categories of women with a relative 
survival of over 100%. At face value this indicates that a woman in such a category has a 
smaller risk of dying than women of the same age in the general population, that is, her 
cancer has had some health benefit. Whilst it is true that diagnosis of a serious disease 
can result in behavioural changes that in turn give health benefits, there is no consistency 
in the ‘over 100%’ figures in the tables. Therefore these numbers should be interpreted as 
normal statistical variation due to small sample sizes and treated with caution. 
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2 Results 
Survival by age 
Age differentials from less than 40 years to 70 years and over 
(Table 2.2, page 9) 
• In general, relative survival was highest in women aged 50–59 years and lowest in 
women aged 70 years and older. 
• From the fifth to the ninth year after diagnosis, relative survival was significantly lower 
in women aged younger than 40 years and women aged 70 years and over compared 
with women from every other age group. 
• Five-year relative survival was 81% in women aged 0–39 years, 86% in women aged  
40–49 years, 90% in women aged 50–59 years, 89% in women aged 60–69 years and 80% 
in women aged 70 years and over. 
Survival by size 
Survival by size and years after diagnosis 
(Table 2.3, page 10) 
• In general, relative survival was highest for women with 0–10 mm tumours and 
decreased steadily as tumour size increased. However, women with unknown tumour 
size had the lowest survival every year after diagnosis. 
• From 5 to 9 years after diagnosis, relative survival was significantly higher for women 
with 0–10 mm tumours compared with women with every other tumour size. 
• For every year after diagnosis, relative survival was significantly lower for women with 
30 mm or greater tumours compared with women with every other known tumour size.  
• Five-year relative survival was 98% for women with 0–10 mm tumours, 95% for women 
with 11–15 mm tumours, 93% for women with 16–19 mm tumours, 88% for women with 
20–29 mm tumours, 73% for women with 30mm or greater tumours and 49% for women 
with tumours of unknown size. 
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Source: National Cancer Statistics Clearing House, AIHW. 
Figure 1: Breast cancer relative survival by size of cancer 
Survival by age and size 
(Table 2.4, page 11) 
• At 1 year after diagnosis, there were no significant differences in relative survival among 
age groups for smaller cancers (sizes 0–10, 11–15 and 16–19 mm). 
• At 5 and 9 years after diagnosis, relative survival was generally lowest in women aged 
younger than 40 years for all known tumour sizes.  
• Five-year relative survival for women with very small tumours (0–10 mm) was 95% for 
those aged younger than 40 years, 97% for ages 40–49 years, 98% for ages 50–59 years, 
97% for ages 60–69 years and 103% for ages 70 years and over. 
Survival by nodal status 
Survival by nodal status and years after diagnosis 
(Table 2.6, page 12) 
• In every year after diagnosis, relative survival was significantly higher for women with 
negative nodal status compared with women with positive nodal status. Women with 
unknown nodal status had the lowest relative survival every year after diagnosis. 
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• Five-year relative survival was 97% for women with negative nodal status, 80% for 
women with positive nodal status and 71% for women with unknown nodal status. 
• The difference in relative survival between women with negative and positive nodal 
status increased steadily with years elapsed following diagnosis. For example, the 
difference in 1-year relative survival between women with positive (98%) and negative 
(100%) nodal status was 2 percentage points, whereas the difference in 9-year relative 
survival between women with positive (70%) and negative (94%) nodal status was 24 
percentage points. 
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Source: National Cancer Statistics Clearing House, AIHW. 
Figure 2: Breast cancer relative survival by nodal status 
Survival by age and nodal status 
(Table 2.7, page 13) 
• At 5 and 9 years after diagnosis, women with negative nodal status had significantly 
higher relative survival compared with women with positive or unknown nodal status 
for all age groups. 
• For example, 5-year relative survival for women aged 50–59 years was 97% for those 
with negative nodal status, 83% for those with positive nodal status and 76% for those 
with unknown nodal status. 
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Survival by place of residence 
Survival by place of residence and years after diagnosis 
(Table 2.9, page 14) 
• In general, relative survival was highest for women who lived in Major Cities and lowest 
for women who lived in Remote and Very Remote areas. However, there were no 
statistically significant differences between areas. 
• Nine-year relative survival was 80% in Major Cities, 79% in Inner Regional areas, 77% in 
Outer Regional areas and 75% in Remote and Very Remote areas, with these differences 
not statistically significant. 
Survival by place of residence and size 
(Table 2.10, page 15) 
• There were generally no significant differences in 1-, 5- and 9-year relative survival 
between women living in different areas for all tumour sizes. 
• However, 1- and 5-year relative survival was significantly higher in women with  
11–15 mm tumours for those living in Major Cities (100% and 95%, respectively) 
compared with those in Outer Regional areas (97% and 88%, respectively). 
Survival by place of residence and nodal status 
(Table 2.12, page 16) 
• One-, five- and nine-year relative survival generally was not significantly different 
between women living in different areas for positive, negative or unknown nodal status.  
Survival by socioeconomic status 
Survival by socioeconomic status and years after diagnosis 
(Tables 2.14 and 2.19, pages 17 and 21) 
Relative survival was analysed by socioeconomic status quintiles and deciles using the  
ABS SEIFA Index of Socioeconomic Disadvantage (see Glossary). 
• From the third year after diagnosis, relative survival was significantly higher for women 
in the most socioeconomically advantaged areas (1st quintile) compared with women in 
the least socioeconomically advantaged areas (4th and 5th quintiles). 
• Five-year relative survival was 89% in the first socioeconomic status quintile, 86% in the 
second quintile, 86% in the third quintile, 84% in the fourth quintile and 84% in the fifth 
quintile. 
• Extending the analysis further using socioeconomic status deciles, a similar pattern was 
found. There was a significant difference between the first and ninth socioeconomic 
status deciles from the fourth year following diagnosis. For example, 5-year relative 
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survival was 90% for women in the first decile and 83% for women in the ninth decile. 
The tenth decile usually presented lower survival than the first decile, but these 
differences were not statistically significant, partly due to the small number of cases in 
the tenth decile. 
Survival by socioeconomic status and size 
(Tables 2.15 and 2.20, pages 18 and 22) 
• In the ninth year after diagnosis, relative survival was highest in women living in the 
most socioeconomically advantaged areas of Australia (1st quintile) for women with all 
known tumour sizes greater than 10 mm. 
• Five-year relative survival was significantly higher in women with 11–15 mm tumours 
for those in the first socioeconomic status quintile (97%) compared with those in the 
fourth quintile (91%). 
• There were inconsistent findings when the analysis was conducted using socioeconomic 
status deciles because of higher standard errors and wider confidence intervals. For 
women with 11–15 mm tumours, 5-year relative survival was significantly higher for 
those in the first socioeconomic status decile (98%) compared with those in the eighth 
decile (89%), but very similar to those in the ninth decile (96%). 
Survival by socioeconomic status and nodal status 
(Tables 2.17 and 2.22, pages 19 and 24) 
• Differences in relative survival between women living in different areas of 
socioeconomic advantage were greater for positive compared with negative nodal status 
and in later years after diagnosis. 
• At 5 and 9 years after diagnosis, relative survival was significantly higher in women 
with positive nodal status for those in the first socioeconomic status quintile compared 
with those in the fifth quintile. 
• For example, 5-year relative survival for women with positive nodal status was 85% in 
the first quintile, 82% in the second quintile, 78% in the third quintile, 78% in the fourth 
quintile and 77% in the fifth quintile. 
• Five-year relative survival for women with negative nodal status was 98% in the first 
quintile, 97% in the second quintile, 97% in the third quintile, 96% in the fourth quintile 
and 95% in the fifth quintile. 
• When the analysis was conducted using socioeconomic deciles, there was more volatility 
in the rates because of smaller numbers and wider confidence intervals. Five-year 
relative survival for women with positive nodal status ranged from 79% for the third 
decile to 85% for the first decile in the first five deciles and from 75% for the sixth decile 
to 81% for the seventh decile in the second five deciles. 
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Table 2.1: Number of cases diagnosed by age and size of cancer, 1997 and deaths from  
1997 to 2006 
  Age at diagnosis 
Size 0–39  40–49  50–59  60–69  70+  Total 
 Number of cases diagnosed 
0–10 mm 123  344  587  511  413  1,978 
11–15 mm 132  405  585  510  516  2,148 
16–19 mm 86  199  270  218  289  1,062 
20–29 mm 145  454  469  433  591  2,092 
30+ mm 134  353  391  294  490  1,662 
Unknown  59  153  172  163  528  1,075 
Total 679   1,908   2,474   2,129   2,827   10,017 
  Deaths from 1997 to 2006 
0–10 mm 14  26  52  88  144  324 
11–15 mm 21  46  73  104  224  468 
16–19 mm 19  38  36  40  148  281 
20–29 mm 51  107  107  132  314  711 
30+ mm 60  130  149  116  338  793 
Unknown  30  72  85  103  456  746 
Total 195  419  502  583  1,624  3,323 
Source: National Cancer Statistics Clearing House, AIHW. 
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Table 2.5: Number of cases diagnosed, nodal status by age, 1997 and  
deaths from 1997 to 2006 
  Nodal status 
Age at 
diagnosis 
Nodes 
positive   
Nodes 
negative   Unknown   Total 
 Number of cases diagnosed 
0–39   275  295  109  679 
40–49   736  869  303  1,908 
50–59 799  1,295  380  2,474 
60–69 591  1,099  439  2,129 
70+    600  1,054  1,173  2,827 
Total 3,001   4,612   2,404   10,017 
  Deaths from 1997 to 2006 
0–39   112  38  45  195 
40–49   229  97  93  419 
50–59 245  141  116  502 
60–69 222  191  170  583 
70+    371  409  844  1,624 
Total 1,179   876   1,268   3,323 
Source: National Cancer Statistics Clearing House, AIHW. 
Table 2.6: Breast cancer survival by nodal status 
  Nodal status 
 Nodes positive  Nodes negative  Unknown  Total 
Years after  
diagnosis % 95% CI   % 95% CI   % 95% CI   % 95% CI 
1 97.7 96.9–98.3  100.0 99.6–100.2  87.2 85.6–88.6  96.3 95.8–96.7 
2 92.4 91.3–93.4  99.3 98.7–99.7  81.9 80.1–83.6  93.2 92.5–93.7 
3 88.1 86.8–89.4  98.4 97.7–99.0  77.2 75.1–79.1  90.4 89.6–91.1 
4 84.2 82.7–85.7  97.6 96.8–98.4  74.0 71.8–76.1  88.1 87.3–88.9 
5 80.2 78.5–81.7  96.5 95.5–97.4  70.7 68.4–72.9  85.6 84.7–86.4 
6 77.3 75.6–79.0  95.2 94.2–96.2  67.6 65.2–70.0  83.4 82.5–84.3 
7 74.4 72.6–76.2  94.7 93.5–95.7  65.7 63.2–68.1  81.8 80.9–82.8 
8 72.0 70.1–73.9  94.0 92.8–95.2  64.4 61.8–66.9  80.5 79.5–81.5 
9 69.7 67.7–71.6   93.5 92.2–94.7   63.4 60.8–66.0   79.3 78.2–80.4 
Source: National Cancer Statistics Clearing House, AIHW. 
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Table 2.7: Breast cancer survival by nodal status and age 
  Nodal status 
 Nodes positive  Nodes negative  Unknown  Total 
Age at 
diagnosis % 95% CI  % 95% CI  % 95% CI  % 95% CI 
 1-year survival 
0–39 98.3 95.8–99.3  99.7 97.7–100.0  90.9 83.7–95.1  97.7 96.3–98.6 
40–49 98.7 97.5–99.3  100.0 99.3–100.1  94.8 91.6–96.9  98.7 98.0–99.1 
50–59 97.8 96.5–98.7  99.8 99.2–100.1  92.4 89.2–94.7  98.0 97.4–98.6 
60–69 97.5 95.7–98.7  100.3 99.6–100.6  87.8 84.3–90.6  97.0 96.0–97.7 
70+ 96.0 93.5–98.0  99.8 98.4–100.8  82.6 79.9–85.0  92.1 90.7–93.3 
 5-year survival 
0–39 73.7 68.1–78.6  92.9 89.2–95.4  69.1 59.4–76.9  81.3 78.2–84.1 
40–49 80.4 77.3–83.2  94.0 92.1–95.5  79.1 74.0–83.4  86.4 84.7–87.9 
50–59 83.4 80.5–85.9  97.1 95.7–98.1  76.4 71.6–80.5  89.5 88.1–90.7 
60–69 82.5 78.8–85.8  97.5 95.7–99.0  76.3 71.7–80.4  89.0 87.3–90.5 
70+ 76.0 71.0–80.7  98.1 94.9–100.9  63.7 59.7–67.5  79.6 77.2–81.8 
 9-year survival 
0–39 60.1 54.0–65.7  88.2 83.8–91.5  59.2 49.3–67.8  72.1 68.6–75.4 
40–49 70.9 67.4–74.2  90.8 88.5–92.7  71.1 65.5–76.0  80.0 78.1–81.8 
50–59 73.8 70.4–76.9  93.4 91.6–95.0  72.8 67.7–77.3  83.9 82.2–85.5 
60–69 72.1 67.7–76.2  93.5 90.9–95.7  69.5 64.3–74.3  82.6 80.5–84.6 
70+ 63.8 57.6–70.1   98.4 93.8–102.8   55.0 50.2–59.9   73.7 70.7–76.8 
Source: National Cancer Statistics Clearing House, AIHW. 
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Glossary 
Cancer (malignant neoplasm): one of several diseases that result when the process of cell 
division, by which tissues normally grow and renew themselves, becomes uncontrolled and 
leads to the development of malignant cells. These cancer cells multiply in an uncoordinated 
way, independently of normal growth control mechanisms, to form a tumour. The tumour 
can expand locally by invasion or systemically by metastasis via the lymphatic or vascular 
systems. If left untreated, most malignant tumours eventually result in death. 
Cancer size: the largest reported diameter of an invasive tumour. For multicentric or 
multifocal cancer, size was taken as the diameter of the largest focus. This applied in all 
jurisdictions except South Australia and the Northern Territory cancer registries where the 
sizes of multicentric and/or multifocal cancers were summed. This latter practice complied 
with standards existing in some registries around 1980 and was still being maintained in 
1997 to facilitate analyses of time trends. The effect has been to artificially increase the 
measure of sizes of South Australian and Northern Territory tumours relative to those for 
other jurisdictions. 
Cancer size groupings: based on the NBCC National protocol for recording 1. size, nodal status 
and grade of invasive breast cancer and 2. carcinoma in situ (Marr et al. 1997), the breast cancer 
size categories used in this report are defined in Table G1. 
Table G1: Definitions of cancer size groups 
Cancer size group Definition 
0–10 mm Cancers equal to or larger than 0.1 mm and equal to or smaller than 10.5 mm 
11–15 mm Cancers larger than 10.5 mm and smaller than 15.5 mm 
16–19 mm Cancers equal to or larger than 15.5 mm and smaller than 19.5 mm 
20–29 mm Cancers equal to or larger than 19.5 mm and smaller than 29.5 mm 
30+ mm Cancers equal to or larger than 29.5 mm  
Unknown Cancers recorded as 0 mm, -1 mm, or 999 mm in size 
 
Cancer records were included in the size group ‘Unknown’ where cancer size was recorded 
as 0 mm. Approximately 11% of women in this report had unknown breast cancer size and 
survival in these women may be poor for a number of reasons. First, size information may be 
unavailable for women in the advanced stages of cancer. Second, women with unknown 
tumour size (mean age at diagnosis = 67 years) were generally older than women with 
known tumour size (mean age at diagnosis = 59 years).  
Confidence interval: a range determined by variability in data, within which there is 
specified (95% in this report) chance that the true value of a calculated parameter (for 
example, relative survival) lies. 
Geographic classification: this report uses a geographic classification known as the 
Australian Standard Geographical Classification (ASGC) Remoteness Area, which groups 
geographic areas into five classes: Major Cities, Inner Regional, Outer Regional, Remote and 
Very Remote. These classes are based on census collection districts (CDs), which aggregate 
into statistical local areas (SLAs) and are defined using the Accessibility/Remoteness Index 
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for Australia (ARIA). ARIA is a measure of the remoteness of a location from the services 
provided by large towns or cities. 
The smallest geographic unit available in this study was the postcode at diagnosis.  
A concordance between SLAs and postcodes was used to obtain the ASGC Remoteness Area 
for postcodes.  
Lymph node: masses of lymphatic tissue, often bean-shaped, that produce lymphocytes and 
through which lymph filters. 
Nodal status: in accordance with the NBCC National protocol for recording 1. size, nodal status 
and grade of invasive breast cancer and 2. carcinoma in situ (Marr et al. 1997), nodal status refers 
to whether excised lymph nodes were found to have cancer in them (positive) or not 
(negative). The ‘Unknown’ nodal status category included cases where no lymph nodes were 
examined and cases where nodal status could not be determined after examination. 
Women with unknown nodal status accounted for approximately 24% of cases in this report. 
Survival in these women may be poor for similar reasons as women with unknown breast 
cancer size. First, nodal status information may be unavailable for women in the advanced 
stages of cancer. Second, women were generally older in the unknown (mean age at 
diagnosis = 67 years) compared with the known (mean age at diagnosis = 58 years) nodal 
status category.  
Relative survival: the ratio of the observed survival rate for a given cohort of cancer patients 
to the expected survival rate in the age-, sex- and calendar year-matched population (see 
Introduction). 
Socioeconomic status: socioeconomic status was coded according to the Index of Relative 
Socioeconomic Disadvantage (IRSD). The IRSD is one of the Socioeconomic Indexes For 
Areas (SEIFA) developed by the Australian Bureau of Statistics to categorise geographic 
areas according to their social and economic characteristics. 
The smallest geographic unit available in this study was the postcode at diagnosis. A 
concordance between postcodes and SLAs was used to obtain the IRSD for postcodes. It is 
important to note that the IRSD relates to the average disadvantage of all people living in a 
geographic area. Hence any variability between groups based on the IRSD will be smaller 
than if the variability had been measured between individuals. 
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